Graphene-Reinforced CAD/CAM Restorations for MIH-Affected Molars in Adolescents: A Prospective Clinical Study

December 28, 2025 updated by: Luis Carlos Garza Garza, Universitat Internacional de Catalunya

Clinical Evaluation of Graphene-Reinforced CAD/CAM Indirect Restorations in Molars Affected by Molar-Incisor Hypomineralization (MIH) in Adolescents: A Clinical Study

This study evaluates the clinical performance, marginal integrity, surface wear, color stability, and postoperative sensitivity of graphene-reinforced CAD/CAM indirect restorations (inlays, onlays, overlays) in molars affected by moderate to severe Molar-Incisor Hypomineralization (MIH) in adolescents. A total of 30 patients aged 10-16 years will receive minimally invasive indirect restorations fabricated from a nano-reinforced graphene polymer (G-CAM®). Clinical outcomes will be assessed using FDI criteria, VAS sensitivity scores, patient satisfaction, and digital 3D scans over a 12-month follow-up. The study aims to determine clinical acceptability and safety compared with historical outcomes reported for composite and lithium-disilicate indirect restorations.

Study Overview

Detailed Description

This is a prospective, single-arm, monocentric clinical trial designed to assess the functional performance, marginal adaptation, wear behavior, postoperative sensitivity, and structural preservation of graphene-reinforced CAD/CAM restorations placed on MIH-affected molars in adolescents aged 10-16 years. MIH lesions present compromised enamel quality with increased porosity, susceptibility to post-eruptive breakdown, and frequent hypersensitivity, making conventional restorative approaches less predictable.

Minimally invasive preparations will be performed followed by adhesive placement of graphene-reinforced CAD/CAM indirect restorations fabricated through a fully digital workflow (intraoral scanning, CAD design, CAM milling). Evaluations will be performed at baseline, 48 h, 1, 3, 6, and 12 months. Primary variables include global and domain-specific FDI clinical scores (marginal integrity, surface roughness, color stability, fractures/chipping, proximal contact, occlusion/function, soft tissue response) and postoperative sensitivity measured using a Visual Analog Scale (VAS). Secondary outcomes include patient satisfaction, tooth vitality, digital volumetric analysis of structural preservation, survival of restorations, and efficiency of the digital workflow.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Barcelona
      • Sarrià-Sant Gervasi, Barcelona, Spain, 08034
        • Dental Esthetic BCN
        • Contact:
          • Luis Carlos Garza Garza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescents aged 10-16 years.
  • Permanent molars with moderate or severe MIH (EAPD criteria).
  • Vital and restorable teeth.
  • Ability to attend follow-up visits.
  • Informed consent from guardian + assent from the minor.

Exclusion Criteria:

  • Fluorosis, amelogenesis imperfecta, or other enamel defects.
  • Severe bruxism not controlled.
  • Active extensive caries or irreversible pulpitis.
  • Systemic conditions affecting enamel or healing.
  • Hypersensitivity/allergy to materials/adhesives.
  • Use of analgesics/AINEs <24 h before baseline VAS.

    • Orthodontic bands on the study molar.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Graphene-Reinforced CAD/CAM Indirect Restoration
Minimally invasive preparation, composite base build-up when indicated, adhesive protocol with total-etch technique, CAD/CAM fabrication using graphene-reinforced polymer (G-CAM®), adhesive cementation under rubber dam isolation, finishing and polishing, and follow-up at 1 week, 3, 6, and 12 months.
Graphene-reinforced CAD/CAM polymer (G-CAM®) used for the fabrication of indirect inlay, onlay, or overlay restorations in permanent molars affected by molar-incisor hypomineralization (MIH). Restorations are fabricated using a digital CAD/CAM workflow and adhesively cemented under rubber dam isolation according to the study protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Acceptability Assessed by the FDI World Dental Federation Clinical Criteria Score
Time Frame: 12 months after restoration placement

Clinical performance of the indirect CAD/CAM graphene-reinforced restoration will be evaluated using the FDI World Dental Federation Clinical Criteria.

Each domain is scored on a 1-5 ordinal scale, where:

  1. = Clinically excellent (best outcome)
  2. = Clinically good
  3. = Clinically acceptable
  4. = Clinically unsatisfactory
  5. = Clinically poor (worst outcome)

Domains assessed:

Marginal integrity

Surface roughness/wear

Color stability

Fractures/chipping

Proximal contact

Occlusion/function

Soft tissue response

Higher scores indicate worse clinical performance. Data will be reported as mean score per domain and global acceptability.

12 months after restoration placement
Postoperative Sensitivity Measured by Visual Analog Scale (VAS 0-10)
Time Frame: Baseline (preoperative), 48 hours, 1 month, 3 months, 6 months, and 12 months

Postoperative sensitivity to cold and mastication will be measured on a 0-10 Visual Analog Scale (VAS), where:

0 = No pain (best outcome)

10 = Worst imaginable pain (worst outcome)

Higher scores indicate worse sensitivity.

Baseline (preoperative), 48 hours, 1 month, 3 months, 6 months, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Satisfaction Measured by 5-Point Likert Scale
Time Frame: 1 month, 3 months, 6 months, and 12 months

Patient satisfaction with the restoration will be measured on a Likert scale from 1 to 5, where:

  1. = Very dissatisfied (worst outcome)
  2. = Dissatisfied
  3. = Neutral
  4. = Satisfied
  5. = Very satisfied (best outcome)

Higher scores indicate higher satisfaction.

1 month, 3 months, 6 months, and 12 months
Change in Tooth Structure Volume Measured by 3D Intraoral Scan Superimposition (mm³)
Time Frame: Baseline and 12 months

Structural preservation will be evaluated by comparing preoperative and 12-month postoperative 3D intraoral scans.

The primary metric is change in tooth volume (mm³) obtained through digital superimposition.

Decreased volume indicates structural loss; minimal change indicates better preservation.

Lower volume loss indicates better structural preservation.

Baseline and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 10, 2026

Primary Completion (Estimated)

April 23, 2026

Study Completion (Estimated)

January 11, 2027

Study Registration Dates

First Submitted

November 30, 2025

First Submitted That Met QC Criteria

December 28, 2025

First Posted (Actual)

January 9, 2026

Study Record Updates

Last Update Posted (Actual)

January 9, 2026

Last Update Submitted That Met QC Criteria

December 28, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared with other researchers. The study involves pediatric participants, and all data will be pseudonymized and stored in secure, access-restricted servers according to GDPR and local ethics requirements. Because the dataset is small, contains sensitive clinical information from minors, and is collected within a single clinical center, sharing IPD may increase the risk of re-identification. Therefore, IPD will not be made available outside the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Demineralization

Clinical Trials on Graphene-reinforced CAD/CAM polymer (G-CAM®)

Subscribe